Researchers
-
Anna Planas Ballvé
Clinical neuropsychiatry and neuropsychology
-
Asunción Ávila
Clinical neuropsychiatry and neuropsychology
Phd -
Dolores Lozano
Clinical neuropsychiatry and neuropsychology
-
Ester Moral Torres
Clinical neuropsychiatry and neuropsychology
-
Irati Zubizarreta
Clinical neuropsychiatry and neuropsychology
Phd -
Joan Bello López
Clinical neuropsychiatry and neuropsychology
Phd -
José Vicente Hervas-garcía
Clinical neuropsychiatry and neuropsychology
Phd -
Juan Bernardo Gómez
Clinical neuropsychiatry and neuropsychology
-
Juan José Mengual
Clinical neuropsychiatry and neuropsychology
-
Laura Gubieras Lillo
Clinical neuropsychiatry and neuropsychology
-
Mª Isabel Gómez Ruiz
Clinical neuropsychiatry and neuropsychology
Phd -
Marta Balagué
Clinical neuropsychiatry and neuropsychology
-
Mercè Leixà
Clinical neuropsychiatry and neuropsychology
-
Mireia Grau
Clinical neuropsychiatry and neuropsychology
-
Monica Prat
Clinical neuropsychiatry and neuropsychology
-
Montse Vacas Moreira
Clinical neuropsychiatry and neuropsychology
-
Nuria Caballol
Clinical neuropsychiatry and neuropsychology
-
Pablo Millet Balance
Clinical neuropsychiatry and neuropsychology
-
Sonia Maria Garcia
Clinical neuropsychiatry and neuropsychology
-
Xavier Cardona
Clinical neuropsychiatry and neuropsychology
Contact the group
Form
Projects
-
- Year 2016
- Hospitalet General Hospital
Bilingualism as a cognitive reserve factor in normal and pathological aging,
-
DISTRICT ATTORNEY:
University Pompeu Fabra-Sr. Albert Costa
-
TYPE E:
PI
-
- Year 2016
- Sant Joan Despí Moisès Broggi Hospital
Cross-sectional, multicenter study to evaluate the involvement of oxidative stress in cognitive impairment in MS patients with a mild course of the disease, treated with first-line drugs vs untreated patients and a control group,
-
DISTRICT ATTORNEY:
Biomedical Research Institute of Lleida
-
TYPE E:
EPA
-
- Year 2016
- L'Hospitalet General Hospital
Linguistic study of L1 and L2 in bilingual Parkinson's patients,
-
DISTRICT ATTORNEY:
Dr. Mª Isabel Gómez
-
TYPE E:
PINE TREE
-
- Year 2016
- Sant Joan Despí Moisès Broggi Hospital
Observational program on the effectiveness and safety of Plegridy™ (peginterferon β-1a) in the real world,
-
DISTRICT ATTORNEY:
Biogen Idec Research Limited
-
TYPE E:
EPA
-
- Year 2016
- Sant Joan Despí Moisès Broggi Hospital
Study Comparing the Transfer of Patients with Acute Stroke and Suspected Cerebral Vaso Occlusion to the Closest Local Stroke Center vs. Direct Transfer to an Endovascular Center in the CATalan territory,
-
DISTRICT ATTORNEY:
ICTUS Vascular Disease Private Foundation
-
TYPE E:
PINE TREE
-
- Year 2016
- Sant Joan Despí Moisès Broggi Hospital
Non-interventional prospective study of patients with mild to moderate Alzheimer's disease and their caregivers in four European countries,
-
DISTRICT ATTORNEY:
Merck Sharp & Dohme Corp.
-
TYPE E:
EPA
-
- Year 2016
- Sant Joan Despí Moisès Broggi Hospital
Study of dabigatran in the early phase of stroke. Study of new neuroimaging markers and biomarkers,
-
DISTRICT ATTORNEY:
Dr. Jerzy Aleksander Krupinski - Mutual University Hospital of Terrassa
-
TYPE E:
EPA
-
- Year 2016
- Sant Joan Despí Moisès Broggi Hospital
Study Comparing the Transfer of Patients with Acute Stroke and Suspected Cerebral Vaso Occlusion to the nearest Local Stroke Center vs. Direct Transfer to an Endovascular Center in the territory
-
DISTRICT ATTORNEY:
ICTUS Private Foundation Vascular Disease
-
TYPE E:
PI
-
- Year 2016
- Dos de Maig Comprehensive Care Center
Quality of life and accidental injuries in patients with epilepsy and generalized tonic-clonic seizures,
-
DISTRICT ATTORNEY:
Laboratorios Esteve SA
-
TYPE E:
EPA
-
- Year 2016
- L'Hospitalet General Hospital
Primary progressive aphasia: clinical, neurolinguistic and neuroimaging study
-
DISTRICT ATTORNEY:
Dr. Mª Isabel Gómez
-
TYPE E:
PINE TREE
- Parkinson's disease in our area
- Psychiatric pathology in neurological diseases
- Bilingualism in dementia, stroke and movement disorders
- Multiple Sclerosis: treatment and quality of life
- Cognitive and fluid biomarkers in neurodegenerative disorders
